| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.074 | 0.2 |